We found that IL10 was increased in Kras4bG12D- and EGFRL858R-induced lung cancer mice, which is consistent with the results in lung cancer patients and indicates that Kras and EGFR activation are involved in IL10 expression and might be positively related to lung cancer formation. This evidence concerns the gene KRAS and lung carcinoma.